Apuzzo MLJ, , Sheikh KMA, & Heiden JS, et al: Definition of cellular immune responses to brain antigens in human head trauma. J Neurosurg 51:317–322, 1979 Apuzzo MLJ, Sheikh KMA, Heiden JS, et al: Definition of cellular immune responses to brain antigens in human head trauma. **J Neurosurg 51:**317–322, 1979
PubMed Apuzzo MLJ, Sheikh KMA, Heiden JS, et al: Definition of cellular immune responses to brain antigens in human head trauma. J Neurosurg 51: 317– 322, 1979 Apuzzo MLJ, Sheikh KMA, Heiden JS, et al: Definition of cellular immune responses to brain antigens in human head trauma. J Neurosurg 51:317–322, 1979 10.3171/jns.1979.51.3.0317 )| false
Bhan AJ, , Reinherz EL, & Poppema S, et al: Location of T cell and major histocompatibility complex antigens in the human thymus. J Exp Med 152:771–782, 1980 Bhan AJ, Reinherz EL, Poppema S, et al: Location of T cell and major histocompatibility complex antigens in the human thymus. **J Exp Med 152:**771–782, 1980
PubMed Bhan AJ, Reinherz EL, Poppema S, et al: Location of T cell and major histocompatibility complex antigens in the human thymus. J Exp Med 152: 771– 782, 1980 Bhan AJ, Reinherz EL, Poppema S, et al: Location of T cell and major histocompatibility complex antigens in the human thymus. J Exp Med 152:771–782, 1980 10.1084/jem.152.4.771 )| false
Bloom HJG, , Richardson WW, & Field JR: Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br Med J 3:181–188, 1970 Bloom HJG, Richardson WW, Field JR: Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. **Br Med J 3:**181–188, 1970
PubMed Bloom HJG, Richardson WW, Field JR: Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br Med J 3: 181– 188, 1970 Bloom HJG, Richardson WW, Field JR: Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br Med J 3:181–188, 1970 10.1136/bmj.3.5716.181 )| false
Braun DP, , Penn RD, & Flannery AM, et al: Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas Neurosurgery 10:203–209, 1982 Braun DP, Penn RD, Flannery AM, et al: Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas **Neurosurgery 10:**203–209, 1982
PubMed Braun DP, Penn RD, Flannery AM, et al: Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas Neurosurgery 10: 203– 209, 1982 Braun DP, Penn RD, Flannery AM, et al: Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas Neurosurgery 10:203–209, 1982 )| false
PubMed Brooks WH, Markesbery WR, Gupta GD, et al: Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 4: 219– 224, 1978 Brooks WH, Markesbery WR, Gupta GD, et al: Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 4:219–224, 1978 10.1002/ana.410040305 )| false
Brooks WH, , Netsky MG, & Normansell DE, et al: Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med 136:1631–1647, 1972 Brooks WH, Netsky MG, Normansell DE, et al: Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. **J Exp Med 136:**1631–1647, 1972
PubMed Brooks WH, Netsky MG, Normansell DE, et al: Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med 136: 1631– 1647, 1972 Brooks WH, Netsky MG, Normansell DE, et al: Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med 136:1631–1647, 1972 10.1084/jem.136.6.1631 )| false
Carrel S, , De Tribolet N, & Gross N: Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells. Eur J Immunol 12:354–357, 1982 Carrel S, De Tribolet N, Gross N: Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells. **Eur J Immunol 12:**354–357, 1982
PubMed Carrel S, De Tribolet N, Gross N: Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells. Eur J Immunol 12: 354– 357, 1982 Carrel S, De Tribolet N, Gross N: Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells. Eur J Immunol 12:354–357, 1982 10.1002/eji.1830120418 )| false
Eggers AE: Autoradiographic and fluorescence antibody studies of the human host immune response to gliomas. Neurology 22:246–250, 1972 Eggers AE: Autoradiographic and fluorescence antibody studies of the human host immune response to gliomas. **Neurology 22:**246–250, 1972
PubMed Eggers AE: Autoradiographic and fluorescence antibody studies of the human host immune response to gliomas. Neurology 22: 246– 250, 1972 Eggers AE: Autoradiographic and fluorescence antibody studies of the human host immune response to gliomas. Neurology 22:246–250, 1972 10.1212/WNL.22.3.246 )| false
Engleman EG, , Benike CJ, & Glickman E, et al: Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man. J Exp Med 154:193–198, 1981 Engleman EG, Benike CJ, Glickman E, et al: Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man. **J Exp Med 154:**193–198, 1981
PubMed Engleman EG, Benike CJ, Glickman E, et al: Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man. J Exp Med 154: 193– 198, 1981 Engleman EG, Benike CJ, Glickman E, et al: Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man. J Exp Med 154:193–198, 1981 10.1084/jem.154.1.193 )| false
Fithian E, , Kung P, & Goldstein G, et al: Reactivity of Langerhans cells with hybridoma antibody. Proc Natl Acad Sci USA 78:2541–2544, 1981 Fithian E, Kung P, Goldstein G, et al: Reactivity of Langerhans cells with hybridoma antibody. **Proc Natl Acad Sci USA 78:**2541–2544, 1981
PubMed Fithian E, Kung P, Goldstein G, et al: Reactivity of Langerhans cells with hybridoma antibody. Proc Natl Acad Sci USA 78: 2541– 2544, 1981 Fithian E, Kung P, Goldstein G, et al: Reactivity of Langerhans cells with hybridoma antibody. Proc Natl Acad Sci USA 78:2541–2544, 1981 10.1073/pnas.78.4.2541 )| false
Gerosa MA, , Olivi A, & Rosenblum ML, et al: Impaired immunocompetence in patients with malignant gliomas: the possible role of Tg-lymphocyte subpopulations. Neurosurgery 10:571–573, 1982 Gerosa MA, Olivi A, Rosenblum ML, et al: Impaired immunocompetence in patients with malignant gliomas: the possible role of Tg-lymphocyte subpopulations. **Neurosurgery 10:**571–573, 1982
PubMed Gerosa MA, Olivi A, Rosenblum ML, et al: Impaired immunocompetence in patients with malignant gliomas: the possible role of Tg-lymphocyte subpopulations. Neurosurgery 10: 571– 573, 1982 Gerosa MA, Olivi A, Rosenblum ML, et al: Impaired immunocompetence in patients with malignant gliomas: the possible role of Tg-lymphocyte subpopulations. Neurosurgery 10:571–573, 1982 10.1227/00006123-198205000-00004 )| false
Gershon RK, , Birnbaum Mokyr M, & Mitchell MS: Activation of suppressor T cells by tumour cells and specific antibody. Nature 250:594–596, 1974 Gershon RK, Birnbaum Mokyr M, Mitchell MS: Activation of suppressor T cells by tumour cells and specific antibody. **Nature 250:**594–596, 1974
PubMed Gershon RK, Birnbaum Mokyr M, Mitchell MS: Activation of suppressor T cells by tumour cells and specific antibody. Nature 250: 594– 596, 1974 Gershon RK, Birnbaum Mokyr M, Mitchell MS: Activation of suppressor T cells by tumour cells and specific antibody. Nature 250:594–596, 1974 10.1038/250594a0 )| false
Gilbert D, , Delpech B, & Chevrier A, et al: Inhibition of in vitro lymphocyte proliferation by brain glycoprotein (NSA 3) and mesenchyme-associated antigen (MAA). Cancer Immunol Immunother 11:211–215, 1981 Gilbert D, Delpech B, Chevrier A, et al: Inhibition of in vitro lymphocyte proliferation by brain glycoprotein (NSA 3) and mesenchyme-associated antigen (MAA). **Cancer Immunol Immunother 11:**211–215, 1981
PubMed Gilbert D, Delpech B, Chevrier A, et al: Inhibition of in vitro lymphocyte proliferation by brain glycoprotein (NSA 3) and mesenchyme-associated antigen (MAA). Cancer Immunol Immunother 11: 211– 215, 1981 Gilbert D, Delpech B, Chevrier A, et al: Inhibition of in vitro lymphocyte proliferation by brain glycoprotein (NSA 3) and mesenchyme-associated antigen (MAA). Cancer Immunol Immunother 11:211–215, 1981 )| false
Hamlin IME: Possible host resistance in carcinoma of the breast: a histological study. Br J Cancer 22:383–401, 1968 Hamlin IME: Possible host resistance in carcinoma of the breast: a histological study. **Br J Cancer 22:**383–401, 1968
PubMed Hamlin IME: Possible host resistance in carcinoma of the breast: a histological study. Br J Cancer 22: 383– 401, 1968 Hamlin IME: Possible host resistance in carcinoma of the breast: a histological study. Br J Cancer 22:383–401, 1968 10.1038/bjc.1968.47 )| false
Hsu SM, , Raine L, & Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580, 1981 Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. **J Histochem Cytochem 29:**577–580, 1981
Husby G, , Hoagland PM, & Strickland RG, et al: Tissue T and B cell infiltration of primary and metastatic cancer. J Clin Invest 57:1471–1482, 1976 Husby G, Hoagland PM, Strickland RG, et al: Tissue T and B cell infiltration of primary and metastatic cancer. **J Clin Invest 57:**1471–1482, 1976
PubMed Husby G, Hoagland PM, Strickland RG, et al: Tissue T and B cell infiltration of primary and metastatic cancer. J Clin Invest 57: 1471– 1482, 1976 Husby G, Hoagland PM, Strickland RG, et al: Tissue T and B cell infiltration of primary and metastatic cancer. J Clin Invest 57:1471–1482, 1976 10.1172/JCI108417 )| false
Jones B: Functional activities of antibodies against brain-associated T cell antigens. II. Stimulation of T cell-induced B cell proliferation. Eur J Immunol 12:30–37, 1982 Jones B: Functional activities of antibodies against brain-associated T cell antigens. II. Stimulation of T cell-induced B cell proliferation. **Eur J Immunol 12:**30–37, 1982
PubMed Jones B: Functional activities of antibodies against brain-associated T cell antigens. II. Stimulation of T cell-induced B cell proliferation. Eur J Immunol 12: 30– 37, 1982 Jones B: Functional activities of antibodies against brain-associated T cell antigens. II. Stimulation of T cell-induced B cell proliferation. Eur J Immunol 12:30–37, 1982 10.1002/eji.1830120108 )| false
Kaszubowski PA, , Husby G, & Tung KSK, et al: T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients. Cancer Res 40:4648–4657, 1980 Kaszubowski PA, Husby G, Tung KSK, et al: T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients. **Cancer Res 40:**4648–4657, 1980
PubMed Kaszubowski PA, Husby G, Tung KSK, et al: T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients. Cancer Res 40: 4648– 4657, 1980 Kaszubowski PA, Husby G, Tung KSK, et al: T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients. Cancer Res 40:4648–4657, 1980 )| false
Kril MP, & Apuzzo MLJ: Observations in the study of T lymphocyte subsets by monoclonal antibodies and flow cytometric analysis in intracranial neoplastic disorders. Clin Neurosurg 30:125–136, 1983 Kril MP, Apuzzo MLJ: Observations in the study of T lymphocyte subsets by monoclonal antibodies and flow cytometric analysis in intracranial neoplastic disorders. **Clin Neurosurg 30:**125–136, 1983
PubMed Kril MP, Apuzzo MLJ: Observations in the study of T lymphocyte subsets by monoclonal antibodies and flow cytometric analysis in intracranial neoplastic disorders. Clin Neurosurg 30: 125– 136, 1983 Kril MP, Apuzzo MLJ: Observations in the study of T lymphocyte subsets by monoclonal antibodies and flow cytometric analysis in intracranial neoplastic disorders. Clin Neurosurg 30:125–136, 1983 10.1093/neurosurgery/30.CN_suppl_1.125 )| false
Ledbetter JA, , Evans RL, & Lipinski M, et al: Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med 153:310–323, 1981 Ledbetter JA, Evans RL, Lipinski M, et al: Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. **J Exp Med 153:**310–323, 1981
PubMed Ledbetter JA, Evans RL, Lipinski M, et al: Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med 153: 310– 323, 1981 Ledbetter JA, Evans RL, Lipinski M, et al: Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med 153:310–323, 1981 )| false
Martin-Achard A, , de Tribolet N, & Louis JA, et al: Immune complexes associated with brain tumors: correlation with prognosis. Surg Neurol 13:161–163, 1980 Martin-Achard A, de Tribolet N, Louis JA, et al: Immune complexes associated with brain tumors: correlation with prognosis. **Surg Neurol 13:**161–163, 1980
PubMed Martin-Achard A, de Tribolet N, Louis JA, et al: Immune complexes associated with brain tumors: correlation with prognosis. Surg Neurol 13: 161– 163, 1980 Martin-Achard A, de Tribolet N, Louis JA, et al: Immune complexes associated with brain tumors: correlation with prognosis. Surg Neurol 13:161–163, 1980 )| false
Medawar PB: Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29:58–69, 1948 Medawar PB: Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. **Br J Exp Pathol 29:**58–69, 1948
PubMed Medawar PB: Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29: 58– 69, 1948 Medawar PB: Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29:58–69, 1948 )| false
Morley TP: The recovery of tumour cells from venous blood draining cerebral gliomas; a preliminary report. Can J Surg 2:363–365, 1959 Morley TP: The recovery of tumour cells from venous blood draining cerebral gliomas; a preliminary report. **Can J Surg 2:**363–365, 1959
PubMed Morley TP: The recovery of tumour cells from venous blood draining cerebral gliomas; a preliminary report. Can J Surg 2: 363– 365, 1959 Morley TP: The recovery of tumour cells from venous blood draining cerebral gliomas; a preliminary report. Can J Surg 2:363–365, 1959 )| false
Palma L, , Di Lorenzo N, & Guidetti B: Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J Neurosurg 49:854–861, 1978 Palma L, Di Lorenzo N, Guidetti B: Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. **J Neurosurg 49:**854–861, 1978
PubMed Palma L, Di Lorenzo N, Guidetti B: Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J Neurosurg 49: 854– 861, 1978 Palma L, Di Lorenzo N, Guidetti B: Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J Neurosurg 49:854–861, 1978 10.3171/jns.1978.49.6.0854 )| false
Paterson PY: Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med 111:119–136, 1960 Paterson PY: Transfer of allergic encephalomyelitis in rats by means of lymph node cells. **J Exp Med 111:**119–136, 1960
PubMed Paterson PY: Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med 111: 119– 136, 1960 Paterson PY: Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med 111:119–136, 1960 10.1084/jem.111.1.119 )| false
Phillips JP, , Eremin O, & Anderson JR: Lymphoreticular cells in human brain tumours and in normal brain. Br J Cancer 45:61–69, 1982 Phillips JP, Eremin O, Anderson JR: Lymphoreticular cells in human brain tumours and in normal brain. **Br J Cancer 45:**61–69, 1982
PubMed Phillips JP, Eremin O, Anderson JR: Lymphoreticular cells in human brain tumours and in normal brain. Br J Cancer 45: 61– 69, 1982 Phillips JP, Eremin O, Anderson JR: Lymphoreticular cells in human brain tumours and in normal brain. Br J Cancer 45:61–69, 1982 10.1038/bjc.1982.8 )| false
Pruss RM: Thy-1 antigen on astrocytes in long-term cultures of rat central nervous system Nature 280:688–690, 1979 Pruss RM: Thy-1 antigen on astrocytes in long-term cultures of rat central nervous system **Nature 280:**688–690, 1979
PubMed Pruss RM: Thy-1 antigen on astrocytes in long-term cultures of rat central nervous system Nature 280: 688– 690, 1979 Pruss RM: Thy-1 antigen on astrocytes in long-term cultures of rat central nervous system Nature 280:688–690, 1979 10.1038/280688a0 )| false
Reinherz EL, , Moretta L, & Roper M, et al: Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. J Exp Med 151:969–974, 1980 Reinherz EL, Moretta L, Roper M, et al: Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. **J Exp Med 151:**969–974, 1980
PubMed Reinherz EL, Moretta L, Roper M, et al: Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. J Exp Med 151: 969– 974, 1980 Reinherz EL, Moretta L, Roper M, et al: Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. J Exp Med 151:969–974, 1980 10.1084/jem.151.4.969 )| false
Reinherz EL, & Schlossman SF: Current concepts in immunology. Regulation of the immune response — inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med 303:370–373, 1980 Reinherz EL, Schlossman SF: Current concepts in immunology. Regulation of the immune response — inducer and suppressor T-lymphocyte subsets in human beings. **N Engl J Med 303:**370–373, 1980
PubMed Reinherz EL, Schlossman SF: Current concepts in immunology. Regulation of the immune response — inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med 303: 370– 373, 1980 Reinherz EL, Schlossman SF: Current concepts in immunology. Regulation of the immune response — inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med 303:370–373, 1980 10.1056/NEJM198008143030704 )| false
Reinherz EL, & Schlossman SF: The differentiation and function of human T lymphocytes. Cell 19:821–827, 1980 Reinherz EL, Schlossman SF: The differentiation and function of human T lymphocytes. **Cell 19:**821–827, 1980
PubMed Reinherz EL, Schlossman SF: The differentiation and function of human T lymphocytes. Cell 19: 821– 827, 1980 Reinherz EL, Schlossman SF: The differentiation and function of human T lymphocytes. Cell 19:821–827, 1980 10.1016/0092-8674(80)90072-0 )| false
Ridley A, & Cavanagh JB: The cellular reactions to heterologous, homologous and autologous skin implanted into brain. J Pathol 99:193–203, 1969 Ridley A, Cavanagh JB: The cellular reactions to heterologous, homologous and autologous skin implanted into brain. **J Pathol 99:**193–203, 1969
PubMed Ridley A, Cavanagh JB: The cellular reactions to heterologous, homologous and autologous skin implanted into brain. J Pathol 99: 193– 203, 1969 Ridley A, Cavanagh JB: The cellular reactions to heterologous, homologous and autologous skin implanted into brain. J Pathol 99:193–203, 1969 10.1002/path.1710990303 )| false
Ridley A, & Cavanagh JB: Lymphocytic infiltration in gliomas: evidence of possible host resistance. Brain 94:117–124, 1971 Ridley A, Cavanagh JB: Lymphocytic infiltration in gliomas: evidence of possible host resistance. **Brain 94:**117–124, 1971
PubMed Ridley A, Cavanagh JB: Lymphocytic infiltration in gliomas: evidence of possible host resistance. Brain 94: 117– 124, 1971 Ridley A, Cavanagh JB: Lymphocytic infiltration in gliomas: evidence of possible host resistance. Brain 94:117–124, 1971 10.1093/brain/94.1.117 )| false
Roszman TL, , Brooks WH, & Elliott LH: Immunobiology of primary intracranial tumors. VI. Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumors. Cancer 50:1273–1279, 1982 Roszman TL, Brooks WH, Elliott LH: Immunobiology of primary intracranial tumors. VI. Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumors. **Cancer 50:**1273–1279, 1982
PubMed Roszman TL, Brooks WH, Elliott LH: Immunobiology of primary intracranial tumors. VI. Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumors. Cancer 50: 1273– 1279, 1982 Roszman TL, Brooks WH, Elliott LH: Immunobiology of primary intracranial tumors. VI. Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumors. Cancer 50:1273–1279, 1982 10.1002/1097-0142(19821001)50:7<1273::AID-CNCR2820500709>3.0.CO;2-5 )| false
Seeger RC, , Danon YL, & Rayner SA, et al: Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody. J Immunol 128:983–989, 1982 Seeger RC, Danon YL, Rayner SA, et al: Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody. **J Immunol 128:**983–989, 1982
PubMed Seeger RC, Danon YL, Rayner SA, et al: Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody. J Immunol 128: 983– 989, 1982 Seeger RC, Danon YL, Rayner SA, et al: Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody. J Immunol 128:983–989, 1982 )| false
Small M: Tumor enhancing T lymphocytes in mice: further studies on characteristics and mechanism of activity. Int J Cancer 29:465–469, 1982 Small M: Tumor enhancing T lymphocytes in mice: further studies on characteristics and mechanism of activity. **Int J Cancer 29:**465–469, 1982
PubMed Small M: Tumor enhancing T lymphocytes in mice: further studies on characteristics and mechanism of activity. Int J Cancer 29: 465– 469, 1982 Small M: Tumor enhancing T lymphocytes in mice: further studies on characteristics and mechanism of activity. Int J Cancer 29:465–469, 1982 10.1002/ijc.2910290417 )| false
Stavrou D, , Anzil AP, & Weidenbach W, et al: Immunofluorescence study of lymphocytic infiltration in gliomas. Identification of T-lymphocytes J Neurol Sci 33:275–282, 1977 Stavrou D, Anzil AP, Weidenbach W, et al: Immunofluorescence study of lymphocytic infiltration in gliomas. Identification of T-lymphocytes **J Neurol Sci 33:**275–282, 1977
Stewart THM: The presence of delayed hypersensitivity reactions in patients towards cellular extracts of their malignant tumors. 2. A correlation between the histologic picture of lymphocyte infiltration of the tumor stroma, the presence of such a reaction, and a discussion of the significance of this phenomenon. Cancer 23:1380–1387, 1969 Stewart THM: The presence of delayed hypersensitivity reactions in patients towards cellular extracts of their malignant tumors. 2. A correlation between the histologic picture of lymphocyte infiltration of the tumor stroma, the presence of such a reaction, and a discussion of the significance of this phenomenon. **Cancer 23:**1380–1387, 1969
PubMed Stewart THM: The presence of delayed hypersensitivity reactions in patients towards cellular extracts of their malignant tumors. 2. A correlation between the histologic picture of lymphocyte infiltration of the tumor stroma, the presence of such a reaction, and a discussion of the significance of this phenomenon. Cancer 23: 1380– 1387, 1969 Stewart THM: The presence of delayed hypersensitivity reactions in patients towards cellular extracts of their malignant tumors. 2. A correlation between the histologic picture of lymphocyte infiltration of the tumor stroma, the presence of such a reaction, and a discussion of the significance of this phenomenon. Cancer 23:1380–1387, 1969 )| false
Takakura K, & Sing OK: Inhibitory role of immunologically competent cells on glioblastoma and its clinical application: in vitro studies, in Fusek I, & Kunc Z (eds): Present Limits of Neurosurgery. Amsterdam: Excerpta Medica, 1972, pp 47–51 Takakura K, Sing OK: Inhibitory role of immunologically competent cells on glioblastoma and its clinical application: in vitro studies, in Fusek I, Kunc Z (eds): Present Limits of Neurosurgery. Amsterdam: Excerpta Medica, 1972, pp 47–51
PubMed Takakura K, Sing OK: Inhibitory role of immunologically competent cells on glioblastoma and its clinical application: in vitro studies, in Fusek I, Kunc Z (eds): Present Limits of Neurosurgery. Amsterdam: Excerpta Medica, 1972, pp 47– 51 Takakura K, Sing OK: Inhibitory role of immunologically competent cells on glioblastoma and its clinical application: in vitro studies, in Fusek I, Kunc Z (eds): Present Limits of Neurosurgery. Amsterdam: Excerpta Medica, 1972, pp 47–51 )| false
Taylor CR: Immunoperoxidase techniques. Practical and theoretical aspects. Arch Pathol Lab Med 102:113–121, 1978 Taylor CR: Immunoperoxidase techniques. Practical and theoretical aspects. **Arch Pathol Lab Med 102:**113–121, 1978
PubMed Taylor CR: Immunoperoxidase techniques. Practical and theoretical aspects. Arch Pathol Lab Med 102: 113– 121, 1978 Taylor CR: Immunoperoxidase techniques. Practical and theoretical aspects. Arch Pathol Lab Med 102:113–121, 1978 )| false
Thomas Y, , Rogozinski L, & Irigoyen OH, et al: Functional analysis of human T cell subsets defined by monoclonal antibodies V Suppressor cells within the activated OKT4+ population belong to a distinct subset. J Immunol 128:1386–1390, 1982 Thomas Y, Rogozinski L, Irigoyen OH, et al: Functional analysis of human T cell subsets defined by monoclonal antibodies V Suppressor cells within the activated OKT4+ population belong to a distinct subset. **J Immunol 128:**1386–1390, 1982
PubMed Thomas Y, Rogozinski L, Irigoyen OH, et al: Functional analysis of human T cell subsets defined by monoclonal antibodies V Suppressor cells within the activated OKT4+ population belong to a distinct subset. J Immunol 128: 1386– 1390, 1982 Thomas Y, Rogozinski L, Irigoyen OH, et al: Functional analysis of human T cell subsets defined by monoclonal antibodies V Suppressor cells within the activated OKT4+ population belong to a distinct subset. J Immunol 128:1386–1390, 1982 )| false
Traugott U, , Reinherz EL, & Raine CS: Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 219:308–310, 1983 Traugott U, Reinherz EL, Raine CS: Multiple sclerosis: distribution of T cell subsets within active chronic lesions. **Science 219:**308–310, 1983
PubMed Traugott U, Reinherz EL, Raine CS: Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 219: 308– 310, 1983 Traugott U, Reinherz EL, Raine CS: Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 219:308–310, 1983 10.1126/science.6217550 )| false
Traugott U, , Stone SH, & Raine CS: Experimental allergic encephalomyelitis — migration of early T cells from the circulation into the central nervous system. J Neurol Sci 36:55–61, 1978 Traugott U, Stone SH, Raine CS: Experimental allergic encephalomyelitis — migration of early T cells from the circulation into the central nervous system. **J Neurol Sci 36:**55–61, 1978
PubMed Traugott U, Stone SH, Raine CS: Experimental allergic encephalomyelitis — migration of early T cells from the circulation into the central nervous system. J Neurol Sci 36: 55– 61, 1978 Traugott U, Stone SH, Raine CS: Experimental allergic encephalomyelitis — migration of early T cells from the circulation into the central nervous system. J Neurol Sci 36:55–61, 1978 10.1016/0022-510X(78)90161-2 )| false
van de Griend RJ, , ten Berge I, & Tanke HJ, et al: Characterization of two subsets of human T_γ_ cells. J Immunol 128:1979–1985, 1982 van de Griend RJ, ten Berge I, Tanke HJ, et al: Characterization of two subsets of human T_γ_ cells. **J Immunol 128:**1979–1985, 1982
PubMed van de Griend RJ, ten Berge I, Tanke HJ, et al: Characterization of two subsets of human Tγ cells. J Immunol 128: 1979– 1985, 1982 van de Griend RJ, ten Berge I, Tanke HJ, et al: Characterization of two subsets of human Tγ cells. J Immunol 128:1979–1985, 1982 )| false
Wahlström T, , Saksela E, & Troupp H: Cell-bound antiglial immunity in patients with malignant tumors of the brain. Cell Immunol 6:161–170, 1973 Wahlström T, Saksela E, Troupp H: Cell-bound antiglial immunity in patients with malignant tumors of the brain. **Cell Immunol 6:**161–170, 1973
PubMed Wahlström T, Saksela E, Troupp H: Cell-bound antiglial immunity in patients with malignant tumors of the brain. Cell Immunol 6: 161– 170, 1973 Wahlström T, Saksela E, Troupp H: Cell-bound antiglial immunity in patients with malignant tumors of the brain. Cell Immunol 6:161–170, 1973 10.1016/0008-8749(73)90019-1 )| false
Wang CY, , Good RA, & Ammirati P, et al: Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemia cells. J. Exp Med 151:1539–1544, 1980 Wang CY, Good RA, Ammirati P, et al: Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemia cells. **J. Exp Med 151:**1539–1544, 1980
PubMed Wang CY, Good RA, Ammirati P, et al: Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemia cells. J. Exp Med 151: 1539– 1544, 1980 Wang CY, Good RA, Ammirati P, et al: Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemia cells. J. Exp Med 151:1539–1544, 1980 10.1084/jem.151.6.1539 )| false
Warnke R, & Levy R: Detection of T and B cell antigens with hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method. J Histochem Cytochem 28:771–776, 1980 Warnke R, Levy R: Detection of T and B cell antigens with hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method. **J Histochem Cytochem 28:**771–776, 1980
PubMed Warnke R, Levy R: Detection of T and B cell antigens with hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method. J Histochem Cytochem 28: 771– 776, 1980 Warnke R, Levy R: Detection of T and B cell antigens with hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method. J Histochem Cytochem 28:771–776, 1980 10.1177/28.8.7003003 )| false
Wood GW, & Morantz RA: Immunohistologic evaluation of the lymphoreticular infiltrate of human central nervous system tumors. J Natl Cancer Inst 62:485–491, 1979 Wood GW, Morantz RA: Immunohistologic evaluation of the lymphoreticular infiltrate of human central nervous system tumors. **J Natl Cancer Inst 62:**485–491, 1979
PubMed Wood GW, Morantz RA: Immunohistologic evaluation of the lymphoreticular infiltrate of human central nervous system tumors. J Natl Cancer Inst 62: 485– 491, 1979 Wood GW, Morantz RA: Immunohistologic evaluation of the lymphoreticular infiltrate of human central nervous system tumors. J Natl Cancer Inst 62:485–491, 1979 10.1093/jnci/62.3.485 )| false
Wood GW, , Morantz RA, & Tilzer SA, et al: Immunoglobulin bound in vivo to Fc receptor-positive cells in human central nervous system tumors. J Natl Cancer Inst 64:411–418, 1980 Wood GW, Morantz RA, Tilzer SA, et al: Immunoglobulin bound in vivo to Fc receptor-positive cells in human central nervous system tumors. **J Natl Cancer Inst 64:**411–418, 1980
PubMed Wood GW, Morantz RA, Tilzer SA, et al: Immunoglobulin bound in vivo to Fc receptor-positive cells in human central nervous system tumors. J Natl Cancer Inst 64: 411– 418, 1980 Wood GW, Morantz RA, Tilzer SA, et al: Immunoglobulin bound in vivo to Fc receptor-positive cells in human central nervous system tumors. J Natl Cancer Inst 64:411–418, 1980 )| false
Wood GW, , Neff JE, & Stephens R: Relationship between monocytosis and T-lymphocyte function in human cancer. J Natl Cancer Inst 63:587–592, 1979 Wood GW, Neff JE, Stephens R: Relationship between monocytosis and T-lymphocyte function in human cancer. **J Natl Cancer Inst 63:**587–592, 1979
PubMed Wood GW, Neff JE, Stephens R: Relationship between monocytosis and T-lymphocyte function in human cancer. J Natl Cancer Inst 63: 587– 592, 1979 Wood GW, Neff JE, Stephens R: Relationship between monocytosis and T-lymphocyte function in human cancer. J Natl Cancer Inst 63:587–592, 1979 10.1093/jnci/63.3.587 )| false
Young H, , Kaplan A, & Regelson W: Immunotherapy with autologous white cell infusions (“lymphocytes”) in the treatment of recurrent glioblastoma multiforme. A preliminary report. Cancer 40:1037–1044, 1977 Young H, Kaplan A, Regelson W: Immunotherapy with autologous white cell infusions (“lymphocytes”) in the treatment of recurrent glioblastoma multiforme. A preliminary report. **Cancer 40:**1037–1044, 1977
PubMed Young H, Kaplan A, Regelson W: Immunotherapy with autologous white cell infusions (“lymphocytes”) in the treatment of recurrent glioblastoma multiforme. A preliminary report. Cancer 40: 1037– 1044, 1977 Young H, Kaplan A, Regelson W: Immunotherapy with autologous white cell infusions (“lymphocytes”) in the treatment of recurrent glioblastoma multiforme. A preliminary report. Cancer 40:1037–1044, 1977 10.1002/1097-0142(197709)40:3<1037::AID-CNCR2820400311>3.0.CO;2-9 )| false
Young HF, , Sakalas R, & Kaplan AM: Inhibition of cell-mediated immunity in patients with brain tumors. Surg Neurol 5:19–23, 1976 Young HF, Sakalas R, Kaplan AM: Inhibition of cell-mediated immunity in patients with brain tumors. **Surg Neurol 5:**19–23, 1976
PubMed Young HF, Sakalas R, Kaplan AM: Inhibition of cell-mediated immunity in patients with brain tumors. Surg Neurol 5: 19– 23, 1976 Young HF, Sakalas R, Kaplan AM: Inhibition of cell-mediated immunity in patients with brain tumors. Surg Neurol 5:19–23, 1976 )| false